Core Viewpoint - Alibaba Health (00241) experienced a decline of 2.02% in stock price, trading at 4.86 CNY per share with a transaction volume of 304 million CNY as of July 31 [1] Group 1: Company Overview - Alibaba Health Information Technology Co., Ltd. is the healthcare flagship platform of Alibaba Group, focusing on self-operated pharmaceutical business, e-commerce platform business, and healthcare and digital services [1] - The company leverages advanced digital technology and operational capabilities to provide accessible, efficient, and safe healthcare services to millions of families, creating an integrated online and offline pharmaceutical health service platform [1] Group 2: Financial Performance - As of the 2024 annual report, Alibaba Health reported total revenue of 30.598 billion CNY and a net profit of 1.432 billion CNY [2]
阿里健康(00241)下跌2.02%,报4.86元/股